Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ERCC5 contributors: mct - updated : 09-09-2016
HGNC name excision repair cross-complementing rodent repair deficiency, complementation group 5
HGNC id 3437
Corresponding disease
COFS3 cerebro-oculo-facio-skeletal syndrome 3
XPG xeroderma pigmentosum, complementation group G
Location 13q33.1      Physical location : 103.498.173 - 103.528.347
Synonym name
  • excision repair cross-complementing rodent repair defect in CHO cells
  • DNA-repair protein complementing XP-G cells
  • XPG-complementing protein
  • Synonym symbol(s) ERCM2, XPGC, COFS3, XPG
    DNA
    TYPE functioning gene
    STRUCTURE 30.16 kb     15 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked Y status confirmed
    RNA
    TRANSCRIPTS type
    text multiple splice sites with low information content
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    15 - 4091 133 1186 - 2001 11266544
  • also called ERCC5-I
  • cryptic exon in intron 1
  • - - - - - - 2001 11266544
  • also called ERCC5-II
  • intron 3 retention
  • - - - - - - 2001 11266544
  • also called ERCC5-III
  • cryptic exon in intron 6
  • - - - - - - 2001 11266544
  • also called ERCC5-IV
  • 5' end of exon 8, cryptic acceptor potential exon skipping
  • - - - - - - 2001 11266544
  • also called ERCC5-V
  • cryptic donor partial retention of intron 8
  • - - - - - - 2001 11266544
  • also called ERCC5-VI
  • intron 9 retention
  • EXPRESSION
    Type ubiquitous
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularheart     Homo sapiens
    Digestivemouthtongue    Homo sapiens
    Endocrineadrenal gland     Homo sapiens
     thyroid     Homo sapiens
    Reproductivefemale systembreast    Homo sapiens
    Urinarykidney     Homo sapiens
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • XPG N terminal domain
  • helix-hairpin-helix class 2 motifs
  • C-terminal region interacts with WRN and also interacts with TFIIH to activate transcription
  • HOMOLOGY
    interspecies homolog to yeast RAD2
    Homologene
    FAMILY
  • XPG/RAD2 endonuclease family
  • XPG subfamily
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus,nucleoplasm
    intracellular,nucleus,chromatin/chromosome
    text
  • predominantly nuclear
  • basic FUNCTION
  • endonuclease,making a excision 5'- 3' on a single strand of DNA (nucleotide excision repair)
  • required non enzymatically for subsequent 5' incision by the XPF/ERCC1 heterodimer
  • involved in transcription-coupled repair (TCR) of oxidative DNA lesions
  • ERCC5 and EXO1 may have an analogous disorder-to-order transition promoted by ssDNA or a partner
  • FEN1, EXO1, ERCC5, and GEN1 are junction specific enzymes that require three separate binding sites for DNA and that incise one base pair into the duplex region of the substrate
  • novel function in S phase that is, at least in part, performed coordinately with WRN, and which may contribute to the severity of the phenotypes that occur upon loss of ERCC5
  • NER factors ERCC5 and ERCC4 are essential for establishing CTCF-dependent chromatin looping between the promoter and terminator of the activated RARB2 gene
  • ERCC5 endonuclease promotes DNA breaks and DNA demethylation at promoters allowing the recruitment of CTCF and gene looping, which is further stabilized by ERCC4
  • is a structure-specific endonuclease required for nucleotide excision repair
  • is an homologous recombination (HRR) protein with important roles in genome stability, suggesting how ERCC5 defects produce severe clinical consequences including cancer and accelerated aging
  • CELLULAR PROCESS nucleotide, repair, nucleotide excision repair
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • component of a complex with RNA POL1, TFII alpha, ERCC6
  • EXO1, ERCC5, and GEN1, whose activities span multiple DNA repair pathways, are members of the 5 prime nuclease superfamily with FEN1
  • INTERACTION
    DNA single stranded DNA binding
    RNA
    small molecule
    protein
  • interacts directly with WRN, which is defective in the premature aging disorder Werner syndrome, and the two proteins undergo similar subnuclear redistribution in S phase and colocalize in nuclear foci
  • interacts directly and functionally with the WRN helicase (stimulates the helicase activity of WRN, and XPG and WRN work cooperatively to anneal two DNA single strands)
  • ERCC4, ERCC5 are essential for establishing CTCF-dependent chromatin looping between the promoter and terminator of the activated RARB2 gene
  • is a partner of BRCA1 and BRCA2 in maintaining genomic stability through homologous recombination (HRR)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) XPG , COFS3
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral   deletion    
    in metastatic prostate carcinoma
    tumoral     --low  
    in sqamous cell carcinoma of the head and neck
    tumoral somatic mutation      
    frameshift mutation in gastric carcinomas with microsatellite instability
    constitutional     --low  
    causes DNA double-strand breaks, chromosomal abnormalities, cell-cycle delays, defective HRR, inability to overcome replication fork stalling, and replication stress (pMID: 26833090)
    Susceptibility
  • to cervical carcinoma
  • to melanoma
  • Variant & Polymorphism SNP
  • His1104Asp or His1104His genotypes associated with increased risk of cervical carcinoma
  • XPG Asp1104His polymorphism was a risk factor for melanoma susceptibility
  • Candidate gene
    Marker
  • biomarker of ovarian cancer prognosis
  • EIF4B, DAXX and ERCC5 are identified as novel prognostic markers for poor survival in diffuse large B-cell lymphoma (DLBCL)
  • Therapy target
    SystemTypeDisorderPubmed
    cancerreproductiveovary
    potential therapeutic target of ovarian cancer response to platinum chemotherapy
    ANIMAL & CELL MODELS